Skip to content

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-004172-11-ES
Enrollment
128
Registered
2011-11-10
Start date
2012-01-20
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Product Name: Fluocinolona Acetónido 0.025% gotas óticas en solución Product Code: Fluocinolona Acetónido 0.025% gotas óticas Pharmaceutical Form: Ear drops, solution INN or Proposed INN: Fluocinolona

Sponsors

Laboratorios SALVAT, S.A.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: 13 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 102 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 13

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Spain

Contacts

Public ContactLIDIA ALMIRALL - RESPONSABLE ESTUDI

ANAGRAM-ESIC, S.L.

l.almirall@anagram-esic.com934515250

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026